theory clinical_55_9
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  PALB2 :: "entity ⇒ bool"
  BindingPartner :: "entity ⇒ bool"
  BRCA2 :: "entity ⇒ bool"
  DNA_DamageSites :: "entity ⇒ bool"
  HRRepair :: "entity ⇒ bool"
  DNA_Damage :: "entity ⇒ bool"
  Encodes :: "event ⇒ bool"
  Localizes :: "event ⇒ bool"
  Links :: "event ⇒ bool"
  To :: "event ⇒ entity ⇒ bool"
  In :: "event ⇒ entity ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  PatientEvent :: "event ⇒ entity ⇒ bool"  (* Renamed to avoid conflict *)
  Promotes :: "event ⇒ bool"
  UndamagedHomologousRepairMolecules :: "entity ⇒ bool"
  RAD51Homolog1 :: "entity ⇒ bool"
  Humans :: "entity ⇒ bool"
  Joining :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  LossPALB2 :: "entity ⇒ bool"
  Disrupts :: "event ⇒ bool"
  Prevents :: "event ⇒ bool"
  Promoting :: "event ⇒ bool"
  By :: "event ⇒ entity ⇒ bool"
  HRR :: "entity ⇒ bool"
  RepairProcess :: "entity ⇒ bool"
  Disruption :: "event ⇒ bool"
  UndamagedRepairMolecules :: "entity ⇒ bool"
  RepairSites :: "entity ⇒ bool"
  DueTo :: "event ⇒ entity ⇒ bool"
  Performing :: "event ⇒ bool"
  Because :: "event ⇒ event ⇒ bool"
  Access :: "event ⇒ bool"
  Action :: "event ⇒ bool"

(* Explanation 1: A patient with a pathogenic mutation in PALB2 encodes a binding partner that localizes BRCA2 to sites of DNA damage and links BRCA1 and BRCA2 in HR repair and DNA damage. *)
axiomatization where
  explanation_1: "∃x y z w v u t e1 e2 e3. Patient x ∧ Mutation y ∧ PALB2 y ∧ BindingPartner z ∧ BRCA2 w ∧ DNA_DamageSites v ∧ HRRepair u ∧ DNA_Damage t ∧ Encodes e1 ∧ Agent e1 x ∧ PatientEvent e1 z ∧ Localizes e2 ∧ Agent e2 z ∧ PatientEvent e2 w ∧ To e2 v ∧ Links e3 ∧ Agent e3 z ∧ PatientEvent e3 w ∧ In e3 u ∧ In e3 t"

(* Explanation 2: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2. BRCA2 x ∧ UndamagedHomologousRepairMolecules y ∧ RAD51Homolog1 z ∧ Humans w ∧ Joining e1 ∧ Agent e1 x ∧ PatientEvent e1 y ∧ Via e1 z ∧ In e1 w ∧ Promotes e2 ∧ Agent e2 x ∧ PatientEvent e2 y"

(* Explanation 3: Loss of PALB2 disrupts the localization of BRCA2 to sites of DNA damage, which directly prevents BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR by disrupting its role in the repair process. *)
axiomatization where
  explanation_3: "∃x y z w v u e1 e2 e3 e4. LossPALB2 x ∧ BRCA2 y ∧ DNA_DamageSites z ∧ UndamagedHomologousRepairMolecules w ∧ HRR v ∧ RepairProcess u ∧ Localizes e1 ∧ Agent e1 y ∧ To e1 z ∧ Disrupts e2 ∧ Agent e2 x ∧ PatientEvent e2 e1 ∧ Prevents e3 ∧ Agent e3 x ∧ PatientEvent e3 y ∧ Promoting e4 ∧ Agent e4 y ∧ PatientEvent e4 w ∧ In e4 v ∧ By e3 u"

(* Explanation 4: The disruption of BRCA2 localization due to the loss of PALB2 prevents BRCA2 from performing its role in HRR, specifically in joining undamaged repair molecules, because BRCA2 cannot access the repair sites. *)
axiomatization where
  explanation_4: "∃x y z w v e1 e2 e3 e4 e5 e6. Disruption e1 ∧ BRCA2 y ∧ LossPALB2 x ∧ HRR z ∧ UndamagedRepairMolecules w ∧ RepairSites v ∧ Localizes e2 ∧ Agent e2 y ∧ DueTo e2 x ∧ Prevents e3 ∧ Agent e3 e1 ∧ PatientEvent e3 y ∧ Performing e4 ∧ Agent e4 y ∧ In e4 z ∧ Joining e5 ∧ Agent e5 y ∧ PatientEvent e5 w ∧ Because e3 (Access e6) ∧ Agent e6 y ∧ PatientEvent e6 v"

theorem hypothesis:
  assumes asm: "LossPALB2 x ∧ BRCA2 y ∧ UndamagedRepairMolecules z"
  (* Hypothesis: Loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR *)
  shows "∀x y z e1 e2. LossPALB2 x ∧ Action e1 ∧ BRCA2 y ∧ UndamagedRepairMolecules z ∧ Joining e2 ∧ Agent e2 y ∧ PatientEvent e2 z ∧ In e2 z ⟶ Prevents e1 e2"
proof -
  (* From the premise, we have known information about LossPALB2, BRCA2, and UndamagedRepairMolecules. *)
  from asm have "LossPALB2 x ∧ BRCA2 y ∧ UndamagedRepairMolecules z" <ATP>
  (* We have a logical relation Implies(D, E), which states that Loss of PALB2 disrupts the localization of BRCA2 to sites of DNA damage, and this disruption prevents BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR. *)
  (* Since we have LossPALB2 x, we can infer the disruption of BRCA2 localization. *)
  then have "Disruption of BRCA2 localization prevents BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR" <ATP>
  (* From this, we can conclude that the action of BRCA2 in joining undamaged repair molecules is prevented. *)
  then show ?thesis <ATP>
qed

end
